Abstract
Dideoxynosine (ddI) is a widely used antiretroviral agent in treatment of HIV infection. Pancreatitis is a serious side effect. Two cases are reported, one with rapid development of a pseudocyst.
Similar content being viewed by others
References
King LR, Siegel MJ, Balfe DM (1995) Acute pancreatitis in children: CT findings of intra- and extrapancreatic fluid collections. Radiology 195: 196–200
Seidlin M, Lambert JS, Dolin R, Valentine FT (1992) Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS 6: 831–835
Butler KM, Venzon D, Henry N, Husson RN, Mueller BU, Balis FM, et al (1993) Pancreatitis in human immunodeficiency virus-infected children receiving di-deoxyinosine. Pediatrics 91: 747–751
Bissuel F, Bruneel F, Habersetzen F, Chassard D, Cotto L, Chevallier M, et al (1994) Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med 235: 367–371
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levin, T.L., Berdon, W.E., Tang, H.B. et al. Dideoxyinosine-induced pancreatitis in human immunodeficiency virus-infected children. Pediatr Radiol 27, 189–191 (1997). https://doi.org/10.1007/s002470050099
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002470050099